While shRNA approaches have their own set of challenges to ensure complete knock down of protein levels are achieved, the availability of gene editing approaches such as CRISPR will pave the way for a better fundamental understanding of the role of JNK (or any other target) in human cancer cell function. Here, MAPK8 is linked to cancer.